These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32112384)

  • 1. Protease-Activated Sensors for In Vivo Imaging of Cell Populations.
    Eschliman K; Bossmann SH
    Methods Mol Biol; 2020; 2126():117-126. PubMed ID: 32112384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multispectral Photoacoustic Imaging of Tumor Protease Activity with a Gold Nanocage-Based Activatable Probe.
    Liu C; Li S; Gu Y; Xiong H; Wong WT; Sun L
    Mol Imaging Biol; 2018 Dec; 20(6):919-929. PubMed ID: 29736563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated nanomaterials for targeted cancer theranostics.
    Chan YC; Hsiao M
    Nanomedicine (Lond); 2017 Sep; 12(18):2153-2159. PubMed ID: 28814163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoactivated Spatiotemporally-Responsive Nanosensors of in Vivo Protease Activity.
    Dudani JS; Jain PK; Kwong GA; Stevens KR; Bhatia SN
    ACS Nano; 2015 Dec; 9(12):11708-17. PubMed ID: 26565752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring Proteolytic Activity in Real Time: A New World of Opportunities for Biosensors.
    Oliveira-Silva R; Sousa-Jerónimo M; Botequim D; Silva NJO; Paulo PMR; Prazeres DMF
    Trends Biochem Sci; 2020 Jul; 45(7):604-618. PubMed ID: 32386890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics.
    Holt BA; Mac QD; Kwong GA
    J Vis Exp; 2018 Jul; (137):. PubMed ID: 30059042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring protease activity in biological tissues using antibody prodrugs as sensing probes.
    Vasiljeva O; Menendez E; Nguyen M; Craik CS; Michael Kavanaugh W
    Sci Rep; 2020 Apr; 10(1):5894. PubMed ID: 32246002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging Proteolytic Activities in Mouse Models of Cancer.
    Pal A; Rehemtulla A
    Methods Mol Biol; 2018; 1731():247-260. PubMed ID: 29318559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achievements and Challenges for Real-Time Sensing of Analytes in Sweat within Wearable Platforms.
    Brothers MC; DeBrosse M; Grigsby CC; Naik RR; Hussain SM; Heikenfeld J; Kim SS
    Acc Chem Res; 2019 Feb; 52(2):297-306. PubMed ID: 30688433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors.
    Nahrendorf M; Waterman P; Thurber G; Groves K; Rajopadhye M; Panizzi P; Marinelli B; Aikawa E; Pittet MJ; Swirski FK; Weissleder R
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1444-51. PubMed ID: 19608968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional surface engineering of C-dots for fluorescent biosensing and in vivo bioimaging.
    Ding C; Zhu A; Tian Y
    Acc Chem Res; 2014 Jan; 47(1):20-30. PubMed ID: 23911118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Active Caspases During Apoptosis Using Fluorescent Activity-Based Probes.
    Edgington-Mitchell LE; Bogyo M
    Methods Mol Biol; 2016; 1419():27-39. PubMed ID: 27108429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor associated macrophages and angiogenesis dual-recognizable nanoparticles for enhanced cancer chemotherapy.
    Cao D; Liang L; Xu Y; Sun J; Lei M; Wang M; Wei Y; Sun Z
    Nanomedicine; 2018 Apr; 14(3):651-659. PubMed ID: 29331387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Detection of miRNA Expression in Tumors Using an Activatable Nanosensor.
    Yoo B; Kavishwar A; Ross A; Pantazopoulos P; Moore A; Medarova Z
    Mol Imaging Biol; 2016 Feb; 18(1):70-8. PubMed ID: 25987466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle-based probes to enable noninvasive imaging of proteolytic activity for cancer diagnosis.
    Anani T; Panizzi P; David AE
    Nanomedicine (Lond); 2016 Aug; 11(15):2007-22. PubMed ID: 27465386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting proteases for cancer theranostic through molecular imaging and drug delivery.
    Mumtaz T; Qindeel M; Asim Ur Rehman ; Tarhini M; Ahmed N; Elaissari A
    Int J Pharm; 2020 Sep; 587():119712. PubMed ID: 32745499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live-Cell Imaging of Protease Activity: Assays to Screen Therapeutic Approaches.
    Chalasani A; Ji K; Sameni M; Mazumder SH; Xu Y; Moin K; Sloane BF
    Methods Mol Biol; 2017; 1574():215-225. PubMed ID: 28315254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saliva-based biosensors: noninvasive monitoring tool for clinical diagnostics.
    Malon RS; Sadir S; Balakrishnan M; Córcoles EP
    Biomed Res Int; 2014; 2014():962903. PubMed ID: 25276835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging and quantifying the dynamics of tumor-associated proteolysis.
    Sameni M; Cavallo-Medved D; Dosescu J; Jedeszko C; Moin K; Mullins SR; Olive MB; Rudy D; Sloane BF
    Clin Exp Metastasis; 2009; 26(4):299-309. PubMed ID: 19082919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo imaging of protease activity by Probody therapeutic activation.
    Wong KR; Menendez E; Craik CS; Kavanaugh WM; Vasiljeva O
    Biochimie; 2016 Mar; 122():62-7. PubMed ID: 26546838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.